Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • investor1989I Offline
    investor1989I Offline
    investor1989
    wrote on sidst redigeret af
    #1682

    Genmabs markedsværdi rundede i dag 50 mia. DKK

    1 Reply Last reply
    0
    • investor1989I Offline
      investor1989I Offline
      investor1989
      wrote on sidst redigeret af
      #1683

      Svarende til mig topsalgsestimat for Dara 😄

      1 Reply Last reply
      0
      • FantomasF Offline
        FantomasF Offline
        Fantomas
        wrote on sidst redigeret af
        #1684

        Godt genmab ikke er blevet opkøbt endnu, det har lige sparet os 360.000 på den Porsche 911 Turbo 😉

        1 Reply Last reply
        0
        • PederTP Offline
          PederTP Offline
          PederT
          wrote on sidst redigeret af
          #1685

          Hellere en DB9'er siger jeg bare
          😄

          1 Reply Last reply
          0
          • G Offline
            G Offline
            gentogen
            wrote on sidst redigeret af
            #1686

            Lidt gammelt nyt men alligevel: Decision Taken to Escalate to the Next Dose Level in a Clinical Trial With HuMax-IL8 in Patients With Advanced Solid Tumors Ongoing at the NCI

            1 Reply Last reply
            0
            • G Offline
              G Offline
              gentogen
              wrote on sidst redigeret af
              #1687

              Plans are to advance the project into multiple combination trials pending completion of the dose escalation part of the ongoing phase I trial. HuMax-IL8 will then potentially be combined with a PD-1/PD-L1 inhibitor, cancer vaccine and with chemotherapy in breast, lung and other cancers.”

              1 Reply Last reply
              0
              • G Offline
                G Offline
                gentogen
                wrote on sidst redigeret af
                #1688

                patients in the first dose cohort have been enrolled and treated for at least 4 weeks at the NCI, and the decision was made to start enrollment in the second dose cohort

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  gentogen
                  wrote on sidst redigeret af
                  #1689

                  http://www.cormorantpharma.com/press-release-decision-taken-to-escalate-to-the-next-dose-level-in-a-clinical-trial-with-humax-il8-in-patients-with-advanced-solid-tumors-ongoing-at-the-nci/

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    gentogen
                    wrote on sidst redigeret af
                    #1690

                    HuMax-IL8 is a monoclonal antibody therapy targeting interleukin-8 (IL-8). IL-8 has been shown to be upregulated in many different solid tumors and is involved in the tumor immunosuppression.

                    1 Reply Last reply
                    0
                    • DarvinD Offline
                      DarvinD Offline
                      Darvin
                      wrote on sidst redigeret af
                      #1691

                      Den med at den brede kreds måske fortsat er nervøse/ ikke forstår GEN. De forstår måske ikke scene skiftet.
                      Efter min opfattelse er GEN gået fra at være et biotekselskab til at være et medico (og biotek) selskab som Novo/ Lundbeck, blot med en udpræget biotekafdeling og med et større upside end de to andre. Det betyder jo at risikoen er bleve ganske som gældende for Novo, når det gælder Darzalex og Arzerra, og de udgør hovedparten af GEN forretningen
                      Præstationer mht salg og udvidelse af marked

                      1 Reply Last reply
                      0
                      • DarvinD Offline
                        DarvinD Offline
                        Darvin
                        wrote on sidst redigeret af
                        #1692

                        markedet/ indikationer vil være i fokus fremover her!!. At de også er et biotekselskab med BL.a. EM1, TF-adc, IL-8, teknologierne samt meget mere på vej, burde gøre at folk strømmede til.
                        Se lige på Novo de sidste 5-10 år - det kommer GEN til at kopiere og så kan man ovenikøbet sove roligt om natten.

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          dohk
                          wrote on sidst redigeret af
                          #1693

                          Jan vil sammenligne
                          s med Regeneron, ikke med Lundbeck;-)

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #1694

                            Link Preview Image
                            Page not found - Market Realist

                            favicon

                            (marketrealist.com)

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bikube
                              wrote on sidst redigeret af
                              #1695

                              Janssen er godt nok hurtige - første kommercielle salg er sket og 45M$ på vej.

                              1 Reply Last reply
                              0
                              • digafarmD Offline
                                digafarmD Offline
                                digafarm
                                wrote on sidst redigeret af
                                #1696

                                Det tog den tid posten var om at nå frem 😉

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bikube
                                  wrote on sidst redigeret af
                                  #1697

                                  Det var da et flot link Solsen. Sikke en opreklamering der er igang over there !!

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #1698

                                    http://www.proinvestor.com/aktienyt/855775/Genmab-naar-milestone-paa-USD-45-mio-i-samarbejdet-med-Janssen-om-DARZALEX™-(daratumumab)

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      JKY_VH
                                      wrote on sidst redigeret af
                                      #1699

                                      Er det oven i det beløb vi fik for godkendelsen?

                                      1 Reply Last reply
                                      0
                                      • FantomasF Offline
                                        FantomasF Offline
                                        Fantomas
                                        wrote on sidst redigeret af
                                        #1700

                                        http://www.marketwatch.com/story/help-my-short-position-got-crushed-and-now-i-owe-e-trade-10644556-2015-11-19 risikoen ved at shorte biotek (og short generelt)

                                        1 Reply Last reply
                                        0
                                        • dingleberryD Offline
                                          dingleberryD Offline
                                          dingleberry
                                          wrote on sidst redigeret af
                                          #1701

                                          De usd 45 mio ER godkendelsen. De bliver trigger'et af første behandlede kommercielle patient

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger